| Life Sciences have been continuously revolutionized both in the rate of data accumulation and in the diversity of the biological information being generated through a multitude of technologies. This industry has dramatically changed over the last 20 years; we are now more in a 'knowledge-limited' rather than 'information-limited' era. |
| The industry is now confronted with the ever-growing problem of transforming these masses of heterogeneous information into integrated and structured knowledge. |
"The challenge today is to overcome the information bottleneck by putting together the right information in a contextualized manner in order to allow research scientists to corroborate heterogeneous pieces of information, and thus to generate pertinent biological knowledge."
Nasri Nahas
CEO, GeneBio |
| GeneBio was founded in 1997 by three eminent scientists, Ron Appel, Amos Bairoch and Denis Hochstrasser, in parallel with the establishment of the Swiss Institute of Bioinformatics (SIB). GeneBio's commercial endeavors debuted in 1998 as we began to give access to the Swiss-Prot database. |
| Since our inception, we have evolved from an initial and continuing mandate to commercialize databases and other products developed by the SIB into a truly global multifaceted bioinformatics company offering a broad spectrum of original solutions. |
